"BPA-Free" Doesn't Automatically Mean Safer: The Problem with BPS and BPF

There's a particular kind of false reassurance that comes with a label. "BPA-free" was supposed to be good news — a sign that industry had listened, regulators had acted, and parents could stop worrying about the plastic bottles, food containers, and sippy cups in their homes. The problem is that removing one chemical doesn't automatically make a product safer. Sometimes it just means swapping in a close chemical cousin that hasn't been studied as thoroughly. Scientists call this "regrettable substitution," and the growing body of evidence around bisphenol S (BPS) and bisphenol F (BPF) is making many researchers deeply uncomfortable.

Here's what the research actually shows — and what it means if you're trying to make informed choices for your family.

What Regrettable Substitution Actually Means

When BPA came under regulatory pressure, manufacturers needed alternatives fast. BPS and BPF were structurally similar to BPA, which made them easy drop-in replacements for polycarbonate plastics, thermal receipt paper, food can linings, and other food-contact materials. The catch: structural similarity to BPA means potential similarity in biological activity.

A 2024 scoping review in Human Reproduction Update examining 107 studies found that BPA alternatives — including BPS and BPF — mirrored BPA's harmful effects on oocyte (egg cell) health, with 94.1% of in vitro studies on BPA alternatives finding at least one adverse effect (Peters et al., Human Reproduction Update, 2024). That's not a fringe finding. It's a consistent signal across a large body of work.

Crucially, these chemicals continue to migrate from packaging into food. A 2025 systematic review confirmed that bisphenols — including BPS and BPF — migrate from food packaging materials into food itself, meaning dietary exposure is ongoing and difficult for families to avoid entirely (Tanzer et al., Reviews on Environmental Health, 2025).

The Endocrine Disruption Problem Didn't Go Away

BPA earned its reputation as an endocrine-disrupting chemical because it interferes with estrogen signaling, among other pathways. BPS and BPF appear to work through overlapping mechanisms.

A 2019 analysis in Diabetes & Metabolism Journal raised early alarms, noting that BPS and BPF share structural and functional similarities with BPA and expressing concern that their safety had not been adequately established before widespread adoption (Moon et al., Diabetes & Metabolism Journal, 2019). That concern has not faded. A 2024 review in International Journal of Molecular Sciences found that bisphenol analogs — the broader class that includes BPS and BPF — are implicated in metabolic disruption and obesity risk through interference with hormone signaling (Dalamaga et al., International Journal of Molecular Sciences, 2024).

A 2024 umbrella review — one of the most methodologically rigorous study designs, synthesizing multiple meta-analyses — found that bisphenol exposure is associated with type 2 diabetes, insulin resistance, polycystic ovary syndrome, obesity, hypertension, and cardiovascular disease in adults, with the note that BPA alternatives had not yet been evaluated in equivalent meta-analyses (Symeonides et al., Annals of Global Health, 2024). That last point matters: the absence of large-scale meta-analytic data on BPS and BPF doesn't mean they're safe. It means we're behind.

Reproductive and Developmental Concerns Are Particularly Acute

This is where the evidence is perhaps most unsettling for parents of children and people of reproductive age.

BPA and its analogs have been linked to endometriosis through multiple intracellular pathways involving estrogen signaling, inflammation, and cell survival mechanisms (Dutta et al., Reproductive Toxicology, 2023). Research published in Journal of Hazardous Materials found that low-dose BPS — at environmentally relevant concentrations — promotes ovarian cancer cell stemness through a mitophagic signaling pathway, raising the question of whether replacing BPA with BPS has meaningfully reduced cancer-related risk (Yuan et al., Journal of Hazardous Materials, 2023). A separate 2025 study found that environmentally relevant doses of BPA and BPS promoted ovarian cancer progression and altered the tumor microenvironment in cell and mouse models (Xu et al., Journal of Hazardous Materials, 2025). These are laboratory and animal findings; they do not show that ordinary exposure causes ovarian cancer in people.

Male reproductive health is also implicated. BPF specifically has been studied for its effects on prostate biology, with a 2024 network toxicology and bioinformatics analysis identifying putative biological targets through which BPF could contribute to prostate injury (Huang et al., Toxicology, 2024). These are mechanistic findings, not clinical diagnoses — but they add to a pattern.

Metabolic Disease Risk Across the Bisphenol Class

The metabolic findings deserve their own section, but most of the human evidence summarized here comes from adults. It should not be read as a direct estimate of risk for children.

A 2025 epidemiological and bioinformatics study found associations between bisphenol exposure and diabetes risk, with biological plausibility supported by pathway analysis (Jie et al., Ecotoxicology and Environmental Safety, 2025). Also in 2025, a study using three statistical models found that co-exposure to bisphenol mixtures — the more realistic scenario since we're exposed to multiple analogs simultaneously — was associated with metabolic disease risk (Zhu et al., Obesity, 2025). Real-world exposure can involve multiple analogs, so mixture analyses can reveal patterns that single-chemical models miss. Because this study was observational and cross-sectional, its associations do not prove that the chemicals caused those conditions.

Most recently, a 2026 study found associations between exposure to bisphenol analogs and anemia risk in young adults — a finding that points toward hematological effects not commonly discussed in the BPA literature (Chang et al., Environment International, 2026).

What This Means in Practice

The honest answer is that we cannot yet quantify the precise risk BPS or BPF poses to any individual child. The research is accumulating, but long-term epidemiological data on BPA alternatives specifically remains thinner than what exists for BPA. That uncertainty cuts both ways: it doesn't justify panic, but it also doesn't justify complacency.

What the evidence does support is practical reduction of exposure where feasible:

Prioritize glass or stainless steel for hot food and drinks when practical. This reduces reliance on food-contact plastic in the conditions where migration is more likely (Tanzer et al., Reviews on Environmental Health, 2025).
Avoid heating food in plastic containers of any kind, including those labeled BPA-free. Heat accelerates chemical migration (Tanzer et al., Reviews on Environmental Health, 2025).
Reduce reliance on packaged foods when practical. The systematic review found that migration varied with temperature, contact time, and food composition, so no single packaging label answers every exposure question (Tanzer et al., Reviews on Environmental Health, 2025).
Don't rely on "BPA-free" as a safety signal. Ask what the replacement is. If a product just says "BPA-free" without specifying the alternative, the question remains open.
Talk to your pediatrician if you have specific concerns about your child's exposure, particularly if your family has risk factors related to metabolic or reproductive health.

The broader lesson of regrettable substitution is a regulatory and scientific one: approving replacement chemicals based primarily on the absence of data, rather than the presence of safety evidence, creates cycles of harm and correction. The 2024 umbrella review specifically recommended that "safety for plastic-associated chemicals in humans cannot be assumed at market entry" and called for independent hazard testing before market release (Symeonides et al., Annals of Global Health, 2024). That's the systemic fix. In the meantime, reducing exposure where you reasonably can is the most defensible path.

Have questions about environmental chemicals and your child's health? Browse our Environmental Health category or speak with your child's healthcare provider about individualized guidance.

References

Dutta, S., et al. (2023). Endocrine disruptors and endometriosis. Reproductive Toxicology. https://pubmed.ncbi.nlm.nih.gov/36436816/
Symeonides, C., et al. (2024). An Umbrella Review of Meta-Analyses Evaluating Associations between Human Health and Exposure to Major Classes of Plastic-Associated Chemicals. Annals of Global Health. https://pubmed.ncbi.nlm.nih.gov/39183960/
Peters, A.E., et al. (2024). Impact of Bisphenol A and its alternatives on oocyte health: a scoping review. Human Reproduction Update. https://pubmed.ncbi.nlm.nih.gov/39277428/
Huang, et al. (2024). Analysis of environmental pollutant Bisphenol F elicited prostate injury targets and underlying mechanisms through network toxicology, molecular docking, and multi-level bioinformatics data integration. Toxicology. https://pubmed.ncbi.nlm.nih.gov/38830480/
Dalamaga, M., et al. (2024). The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/38203845/
Moon, M.K., et al. (2019). Concern about the Safety of Bisphenol A Substitutes. Diabetes & Metabolism Journal. https://pubmed.ncbi.nlm.nih.gov/30793551/
Tanzer, et al. (2025). Phthalates, bisphenols and per- and polyfluoroalkyl substances migration from food packaging into food: a systematic review. Reviews on Environmental Health. https://pubmed.ncbi.nlm.nih.gov/40665485/
Xu, et al. (2025). Bisphenols exposure at environmentally relevant dose promoted ovarian cancer progression and modulated tumor microenvironment through β-catenin/SPP1 axis. Journal of Hazardous Materials. https://pubmed.ncbi.nlm.nih.gov/40054195/
Zhu, et al. (2025). Associations between coexposure to bisphenols mixture and metabolic diseases: based on three statistical models. Obesity. https://pubmed.ncbi.nlm.nih.gov/40641007/
Yuan, et al. (2023). Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling. Journal of Hazardous Materials. https://pubmed.ncbi.nlm.nih.gov/36989771/
Jie, et al. (2025). Investigating the association between bisphenols and diabetes: Evidence from epidemiological and bioinformatics. Ecotoxicology and Environmental Safety. https://pubmed.ncbi.nlm.nih.gov/41027195/
Chang, et al. (2026). Exposure to bisphenol analogues and risk of anemia in young adults. Environment International. https://pubmed.ncbi.nlm.nih.gov/41643371/